Supportive Care News & Features
Patients prefer physicians who convey a more optimistic message, and perceive in them a higher level of compassion.
As key biologics near the end of their patent-protection periods, industry is preparing for legal battles over biosimilar versions.
Research highlights how lack of guidelines regarding illness and adequate staffing at hospitals may be reason for oncologists working while sick.
Patients enrolled in hospice care had lower rates of healthcare utilization, and their costs for care were less during their last year of life.
Poor health outcomes for many survivors, especially survivors of multiple myeloma, pancreatic cancer.
More in Supportive Care
ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.
Inadequate pain management, baseline pain severity linked to pain deterioration
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
A Canadian study has identified factors associated with opioid prescriptions for severe pain in the elderly: younger age, male sex, comorbid illness, type of cancer, and assessment at home, results of a study in the Journal of Clinical Oncology published online February 27 has found.
Intrathecal Therapy Cost-Effective for Patients with Cancer Pain Who Have a Favorable Life-Expectancy
In selected patients with cancer pain on high-cost conventional regimens, intrathecal therapy may become cost-effective as early as seven months following implant, and greater duration of therapy is associated with reduced costs.
Rates of inpatient palliative care consultation remain low and occur close to death irrespective of race/ethnicity.
Most adolescents and young adults (AYAs) with cancer received medically intensive end-of-life (EOL) care measures.
Between 2000 and 2012, use of durable power of attorney increased significantly but no association established with end-of-life care decisions.
International experts reached consensus on the makeup of integration of oncology and palliative care.
Earlier palliative care consultation is associated with lower cost of hospital stay for patients with advanced cancer.
The FDA has approved rolapitant (Varubi) in combination with other antiemetic agents for the prevention of delayed nausea and vomiting.
Acupuncture appears to be more efficacious than oral medication for treating hot flashes in breast cancer survivors.
Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity
Acute peripheral neuropathy often does not resolve between cycles of treatment and severity often increases between cycles.
Live and recorded perioperative music therapy reduces anxiety in patients undergoing surgery for potential or known breast cancer.
Ultimately, pulmonary arterial hypertension may occur in as many as 5% of patients with leukemia being treated with dasatinib.
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- Immunotherapy Combinations for Renal Cell Carcinoma Offer Promise, Challenges
- ASCO Updates Metastatic Lung Cancer Therapy Guideline to Include Targeted Agents, Early Palliative Care
- The association between obesity and gastrointestinal cancer
- Association of 21-Gene Recurrence Score Assay, Chemo in Early-stage Breast Cancer
- Patupilone Shows Activity in Recurrent NSCLC Brain Metastases
- Molecular Profiles Can be Used for Early Detection for Aggressive Prostate Cancer
- Thyroid Carcinoma Treatment Regimens
- Combining Aromatase Inhibitors, Bisphosphonates May Benefit Women With Breast Cancer
- Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity
- Better Preoperative Coordination of Care Needed for Patients With Lung Cancer
- Non-Hodgkin Lymphoma (NHL) Treatment Regimens: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
- We Can Treat Hodgkin's Lymphoma Like Melanoma?
- Lymphadenectomy Extent During Esophageal Cancer Surgery May Not Impact Survival
- Risk for SNL Positivity Lower in Melanoma with Histologic Regression
- Targeted Therapy Based on Tumor Molecular Profiling May Not Improve Survival
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|